What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Radiology
- Cancer
The scientist’s investigation covers issues in Radiology, Internal medicine, Surgery, Nuclear medicine and Lung.
Jonathan G. Goldin has included themes like Calcium and Idiopathic pulmonary fibrosis, Usual interstitial pneumonia in his Radiology study.
His research integrates issues of Gastroenterology, Oncology and Cardiology in his study of Internal medicine.
In the field of Surgery, his study on Randomized controlled trial overlaps with subjects such as Placebo.
Jonathan G. Goldin interconnects Differential diagnosis, Medical literature, COPD and Asthma in the investigation of issues within Lung.
His research in Scleroderma intersects with topics in Cyclophosphamide, Intensive care and Interstitial lung disease.
His most cited work include:
- Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis (1912 citations)
- Assessment of coronary artery disease by cardiac computed tomography : A scientific statement from the american heart association committee on cardiovascular imaging and intervention, council on cardiovascular radiology and intervention, and committee on cardiac imaging, council on clinical cardiology (1196 citations)
- Cyclophosphamide versus placebo in scleroderma lung disease. (1084 citations)
What are the main themes of his work throughout his whole career to date?
Jonathan G. Goldin spends much of his time researching Radiology, Internal medicine, Lung, Nuclear medicine and Interstitial lung disease.
Radiology is closely attributed to Idiopathic pulmonary fibrosis in his research.
His Internal medicine research incorporates themes from Gastroenterology and Cardiology.
His work deals with themes such as Fibrosis, Pathology and Pulmonary function testing, which intersect with Lung.
His Interstitial lung disease research includes themes of High-resolution computed tomography, Clinical trial, Surgery, Cyclophosphamide and Scleroderma.
The study incorporates disciplines such as Respiratory disease and Prostate cancer in addition to Surgery.
He most often published in these fields:
- Radiology (39.47%)
- Internal medicine (28.95%)
- Lung (21.71%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (28.95%)
- Interstitial lung disease (16.78%)
- FEV1/FVC ratio (12.50%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Interstitial lung disease, FEV1/FVC ratio, Vital capacity and Gastroenterology are his primary areas of study.
Jonathan G. Goldin undertakes multidisciplinary studies into Internal medicine and Placebo in his work.
Jonathan G. Goldin combines subjects such as Scleroderma, Cyclophosphamide, Idiopathic pulmonary fibrosis and Clinical trial with his study of Interstitial lung disease.
His study looks at the relationship between FEV1/FVC ratio and topics such as Clinical endpoint, which overlap with Hazard ratio.
His Vital capacity study combines topics from a wide range of disciplines, such as Immunosuppression and DLCO.
Jonathan G. Goldin has researched Radiology in several fields, including Clear cell renal cell carcinoma and Disease.
Between 2018 and 2021, his most popular works were:
- The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society (550 citations)
- The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic (171 citations)
- Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial. (44 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Radiology
Jonathan G. Goldin focuses on Interstitial lung disease, Internal medicine, Lung, FEV1/FVC ratio and Idiopathic pulmonary fibrosis.
His Interstitial lung disease research is multidisciplinary, incorporating elements of Vital capacity and Intensive care medicine.
The Lung study combines topics in areas such as Cyclophosphamide and Scleroderma.
The FEV1/FVC ratio study which covers Randomized controlled trial that intersects with Tocilizumab.
His study in Idiopathic pulmonary fibrosis is interdisciplinary in nature, drawing from both Feature, Concordance, Proportional hazards model and Radiology, Pulmonary function testing.
His Radiology research is multidisciplinary, incorporating perspectives in Descending aorta and Analytics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
